NCT00788463 is a Phase 2 clinical trial of Intranasal Beclomethasone aerosol in Nasal Polyps, sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's.

What drugs are being tested in NCT00788463?

Interventions in NCT00788463: Intranasal Beclomethasone aerosol, Intranasal Beclomethasone spray.

What condition does NCT00788463 study?

NCT00788463 studies Nasal Polyps.

Is NCT00788463 still recruiting?

NCT00788463 is currently completed. Last updated 28 August 2017.

Last reviewed 2017-08-28 · How we verify

NCT00788463

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps

Completed Phase 2 Last updated 28 August 2017

What this trial tests

Phase 2 trial testing Intranasal Beclomethasone aerosol in Nasal Polyps in 30 participants. Completed in 30 November 2011.

Timeline

23 November 2006

Primary endpoint
30 March 2009

30 November 2011

Quick facts

Lead sponsor	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	30
Start date	23 November 2006
Primary completion	30 March 2009
Estimated completion	30 November 2011
Sites	1 location across Canada

Drugs / interventions tested

Intranasal Beclomethasone aerosol — full drug profile →
Intranasal Beclomethasone spray — full drug profile →

Conditions studied

Nasal Polyps — all drugs for Nasal Polyps →

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Who can join

18 and older, any sex, with Nasal Polyps. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if intranasal Beclomethasone delivered by aerosol or spray is more effective in treatment of nasal polyps.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Different types of intranasal steroids for chronic rhinosinusitis.
Chong LY, Head K, Hopkins C, Philpott C, et al · · 2016 · cited 55× · PMID 27115215 · DOI 10.1002/14651858.cd011993.pub2

Verify or expand the search:

Other recruiting trials for Nasal Polyps

Currently open trials in the same condition.

NCT07245329 — Effect of Full-House ESS With Nasopharyngeal Lymphoid Tissue Ablation on Nasal Polyps · NA · recruiting
NCT07268313 — Complete Remission After Treatment With Biologics for Nasal Polyps · Phase 4 · recruiting
NCT05575037 — Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease · Phase 2 · active not recruiting
NCT05094570 — Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP · Phase 4 · recruiting
NCT05287841 — Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction? · NA · recruiting

Other London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's trials

Trials by the same sponsor.

NCT07588711 — Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Neuropathic Pain Following Spinal Cord Injury · NA · not yet recruiting
NCT07585292 — Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Musculoskeletal Pain in Cerebral Palsy · NA · not yet recruiting
NCT07510906 — Evaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer · NA · not yet recruiting
NCT03166072 — Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers · NA · not yet recruiting
NCT06035809 — Sensory Motor Arousal Regulation Treatment (SMART) Study · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00788463 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Last refreshed: 28 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00788463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing